Cancer Patients clinical trials

Explore recruiting cancer patients clinical trials.

Recruiting cancer patients studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cancer Patients trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II Trial of atezolizumab plus carboplatin plus nab-paclitaxel as first-line therapy in metastatic Triple-negative PD-L1 positive breast cancer patients

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase II randomized clinical study of the combination of avelumab plus cetuximab as rechallenge strategy in pre-treated RAS/BRAF wild type metastatic colorectal cancer patients

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Induction of neo-antigen specific T cells by specialized cross-presenting dendritic cells in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy, the NEODOC study

Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

CAPRI-3 Phase 3 clinical study to evaluate the use of continuing cetuximab treatment beyond first line progression in molecular selected metastatic colorectal cancer patients

Italy, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase 2 study of trifluridine/tipiracil in patients with ER-positive, HER2-negative advanced breast cancer that previously received chemotherapy (BOOG 2019-01 TIBET study)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

PARP-PET in solid tumors

Sweden

Human Pharmacology (Phase I)- Other EU CTIS Study details

Cancer Patients trials by city

Cancer Patients in Toronto Cancer Patients in Vancouver Cancer Patients in Montreal Cancer Patients in Calgary Cancer Patients in Edmonton Cancer Patients in Ottawa Cancer Patients in Winnipeg Cancer Patients in Quebec City Cancer Patients in Hamilton Cancer Patients in Kitchener Cancer Patients in London Cancer Patients in Halifax Cancer Patients in New York Cancer Patients in Los Angeles Cancer Patients in Chicago Cancer Patients in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease